DHR Health Institute for Research and Development Recognized as a “Top Performing Site” Once Again

Translate to Spanish or other 102 languages!

THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image
THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image
- Advertisement -

EDINBURG, Texas – The DHR Health Institute for Research and Development is delighted to announce that it has once again been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This marks the third consecutive time the Institute has received this prestigious distinction.

This recognition highlights the ongoing excellence and impact of the Research Institute as it continues to advance cancer research and improve patient outcomes.

“We are deeply honored and this recognition would not be possible without the assistance of the DHR Health Oncology Institute and the leadership of Dr. Jose Cruz,” said Dr. Scott Lillibridge, executive vice president for the DHR Health Institute for Research and Development.

- Advertisement -

SWOG is a global cancer research community supported by the National Cancer Institute (NCI), and recognition as a “Top Performing Site” signifies exceptional performance in clinical trial enrollment, data quality, and patient care standards.

The DHR Health Institute for Research and Development remains committed to innovation and delivering high-quality research opportunities to all residents of the Rio Grande Valley. They are located at 5323 S. McColl Road in Edinburg. For more information about clinical trials in the areas of liver, obesity, cancer, neurology, oncology and urology, call the Institute at (956) 362-2390.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Seven Years of Persistence Opens a New Chapter in Valley Cancer Care

Texas Oncology’s new McAllen West clinic is designed to shorten the distance between Rio Grande Valley cancer patients and the testing and treatment they need, Dr. Guillermo Lazo, area medical director for the Rio Grande Valley, said during the facility’s Sept. 29 grand opening.

Texas Oncology Deepens Rio Grande Valley Commitment With McAllen West Expansion

Texas Oncology’s expansion in McAllen represents a renewed commitment to providing cancer patients in the Rio Grande Valley access to advanced care without requiring them to leave their communities, Dr. Steven Paulson said during the Sept. 29 grand opening of Texas Oncology McAllen West.

CANCELED DUE TO WEATHER: DHR Health’s “Walk and Talk with a Doc” for Breast Cancer Awareness

The month of October is “Breast Cancer Awareness Month,” and DHR Health’s Oncology Institute will host “Walk and Talk with a Doc” event on October 1, 2026, at 6:30 p.m. The free event will take place at the DHR Health Heart Institute parking lot, located at 5525 Doctors Drive in Edinburg. Everyone is invited. Attendees are encouraged to wear pink in support of the fight against breast cancer.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -